Introduction：Basic information about CAS 2480-41-3|(Phe2,Orn8)-Oxytocin trifluoroacetate salt, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | (Phe2,Orn8)-Oxytocin trifluoroacetate salt |
|---|
| CAS Number | 2480-41-3 | Molecular Weight | 992.176 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 1536.7±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H65N13O11S2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 883.2±34.3 °C |
|---|
Names
| Name | [Phe2,Orn8]-Oxytocin |
|---|
| Synonym | More Synonyms |
|---|
BiologicalActivity
| Description | (Phe2,Orn8)-Oxytocin is a selective V1 vasopressin agonist. (Phe2,Orn8)-Oxytocin induces a sustained contractility of rabbit epididymis with EC50 value of 280 nM[1]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Vasopressin ReceptorResearch Areas >>Neurological Disease |
|---|
| References | [1]. Sandra Filippi, et al. Estrogens, But Not Androgens, Regulate Expression and Functional Activity of Oxytocin Receptor in Rabbit Epididymis. Endocrinology. 2002, 4271-4280. |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 1536.7±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H65N13O11S2 |
|---|
| Molecular Weight | 992.176 |
|---|
| Flash Point | 883.2±34.3 °C |
|---|
| Exact Mass | 991.436768 |
|---|
| PSA | 455.92000 |
|---|
| LogP | -5.21 |
|---|
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.556 |
|---|
| InChIKey | BSYJBXQZRHPHRD-OVCMMVBBSA-N |
|---|
| SMILES | CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(N)C=S)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CCCN)C(=O)NCC(N)=O |
|---|
| Water Solubility | Slightly soluble (7.8 g/L) (25 ºC) |
|---|
Synonyms
| H-CYS-PHE-ILE-GLN-ASN-CYS-PRO-ORN-GLY-NH2,(DISULFIDE BOND) |
| (PHE2,ORN8)-OXYTOCIN |
| [Phe2,Orn8]OT |
| CYS-PHE-ILE-GLN-ASN-CYS-PRO-ORN-GLY-NH2 |
| (PHE2,ILE3,ORN8)-VASOPRESSIN |
| H-CYS-PHE-ILE-GLN-ASN-CYS-PRO-ORN-GLY-NH2 |
| oxytocin,Phe(2)-Orn(8) |
| [PHE2,ORN8] VASOTOCIN |
| Glycinamide, 1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-16-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-yl]carbonyl]-L-prolyl-L-ornithyl- |
| 1-({(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-benzyl-13-[(2S)-2-butanyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-ornithylglycinamide |
| (Phe2,Orn8)-Oxytocin (Phe2,Ile3,Orn8)-Vasopressin |
| CYS-PHE-ILE-GLN-ASN-CYS-PRO-ORN-GLY-NH2 (DISULFIDE BRIDGE:CYS1-CYS6) |
| 2-L-Phenylalanine-8-L-ornithine-oxytocin |
